K193103

Substantially Equivalent

NeoBase 2 Non-derivatized MSMS Kit

Applicant: Perkinelmer, Inc.
Product code: NQL
Advisory panel: Clinical Chemistry
Date received: 2019-11-08
Decision date: 2020-02-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Waltham, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.